IL‑15 is decreased upon CsA and FK506 treatment of acute rejection following heart transplantation in mice
- Zhiyong Yu
- Xiaoping Zhou
- Songfeng Yu
- Haiyang Xie
- Shusen Zheng
Affiliations: Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
- Published online on: October 20, 2014 https://doi.org/10.3892/mmr.2014.2703
Copyright: © Yu
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License [CC BY_NC 3.0].
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
The aim of this study was to investigate the effect of cyclosporine A (CsA) and tacrolimus (FK506) on interleukin‑15 (IL‑15) production during acute rejection following heart transplantation in mice. Inbred male Balb/c (H‑2d) and C57BL/6 (H‑2b) mice were used to establish a heterotopic intra‑abdominal cardiac transplantation model. The mice were divided in four groups: syngeneic control, allogeneic acute rejection, allogeneic rejection treated with CsA, and allogeneic rejection treated with FK506. The expression of IL‑15, IL‑2, and tumor necrosis factor‑α (TNF‑α) was measured using reverse transcription‑polymerase chain reaction (RT‑PCR) and western blotting. A low level of IL‑15 was detected in transplanted hearts of the control group, with a significant increase observed in the allogeneic acute rejection group. Compared to the allogeneic acute rejection group, IL‑15 expression was significantly decreased in the CsA‑and FK506‑treated allogeneic rejection groups. The TNF‑α expression pattern was similar to that of IL‑15 in all groups. IL‑2 expression was increased in the allogeneic acute rejection group and was inhibited in mice treated with CsA and FK506. In conclusion, increased IL‑15 expression in rejected murine heart grafts may be reduced by CsA and FK506 in vivo.